Ji Xiao-yan, Huang Qiang, Dong Jun, Zhu Yu-de, Wang Ai-dong, Lan Qing
Department of Neurosurgery and Brain Tumor Research Laboratory, Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Zhonghua Yi Xue Za Zhi. 2006 Jun 20;86(23):1604-9.
To pursue the changes of cell morphology, expression of differentiation related markers, and proliferation cycles of brain tumor stem cells (BTSCs) after differentiation in vitro.
Tumor stem cells of the line CD133(+) were obtained from two specimens from one clinical case with anaplasia ependymocytoma during operation, one specimen being obtained during the first operation and then second specimen being obtained during the second operation 6 months later on the recurrent tumor. CD133(+) cells were acquired by using magnetic sorting and then cultured to differentiate in medium containing 10% fetal bovine serum. The morphology of the cells was observed under phase contrast microscope. Cells were collected respectively before differentiation and 3, 7, 10, and 21 days after the differentiation. The cell surface markers such as CD133, nestin, glial fibrillary acidic protein (GFAP), and beta-tubulin III were detected with flow cytometry. Proliferation cycles were examined before differentiation and in the 7th day after differentiation. Normal neural stem cells (NSCs) obtained from fetal brain tissues were used as controls.
(1) The BTSCs were round shape at the beginning, then changed to short fusiform, polygon and long fusiform. Seven days later the cells reversed to short fusiform and round shape. The cells accumulated into cell spheres and floated in the culture medium again. While the NSCs differentiated along their routine rules. (2) Both the undifferentiated BTSCs and NSCs showed high level expression of CD133 and nestin. After differentiation the BTSCs expressed CD133 and nestin, the expression levels decreased first and then increased. The expression rates of CD133 and nestin were (3.65 +/- 0.17)% and (28.99 +/- 1.26)% in the 7th day, (14.63 +/- 1.16)% and (45.46 +/- 1.27)% in the 21st day. While the positive expression rate of GFAP was higher than that of beta-tubulin III. In the 10th day the NSCs under differentiation lost the expression of CD133 and nestin. The percentage of GFAP positive cells and beta-tubulin III positive cells were (88.94 +/- 1.23)% and (11.94 +/- 0.36)% respectively. (3) All undifferentiated BTSCs were hypodiploid. After differentiation majority of the BTSCs were hypodiploid or hyperdiploid, The percentages of S phase and G(2)-M phase cells in the BTSCs were higher than that in the NSCs. The cell composition of recrudescent BTSCs was more complex than that of the primary BTSCs. All NSCs were diploid whether differentiated or not. Most of the NSCs were G(0)-G(1) phase cells.
The differentiation direction of BTSCs is quietly different from that of the NSCs. There is an obvious dysdifferentiation in BTSCs.
探讨脑肿瘤干细胞(BTSCs)体外分化后细胞形态、分化相关标志物表达及增殖周期的变化。
从1例间变性室管膜瘤患者手术切除的2个标本中获取CD133(+)肿瘤干细胞系,第1个标本取自首次手术,第2个标本取自6个月后复发肿瘤的二次手术。采用磁珠分选法获取CD133(+)细胞,然后在含10%胎牛血清的培养基中培养使其分化。在相差显微镜下观察细胞形态。分别在分化前及分化后3、7、10和21天收集细胞。用流式细胞术检测细胞表面标志物如CD133、巢蛋白、胶质纤维酸性蛋白(GFAP)和β-微管蛋白III。在分化前及分化后第7天检测增殖周期。以从胎儿脑组织中获取的正常神经干细胞(NSCs)作为对照。
(1)BTSCs开始时呈圆形,随后变为短梭形、多边形和长梭形。7天后细胞又变回短梭形和圆形。细胞聚集成细胞球并再次漂浮在培养基中。而NSCs按其常规规律分化。(2)未分化的BTSCs和NSCs均高表达CD133和巢蛋白。分化后BTSCs表达CD133和巢蛋白,表达水平先降低后升高。CD133和巢蛋白的表达率在第7天分别为(3.65±0.17)%和(28.99±1.26)%,在第21天分别为(14.63±1.16)%和(45.46±1.27)%。而GFAP的阳性表达率高于β-微管蛋白III。在分化第10天,分化中的NSCs失去CD133和巢蛋白的表达。GFAP阳性细胞和β-微管蛋白III阳性细胞的百分比分别为(88.94±1.23)%和(11.94±0.36)%。(3)所有未分化的BTSCs均为亚二倍体。分化后大多数BTSCs为亚二倍体或超二倍体,BTSCs中S期和G(2)-M期细胞的百分比高于NSCs。复发BTSCs的细胞组成比原发BTSCs更复杂。所有NSCs无论是否分化均为二倍体。大多数NSCs为G(0)-G(1)期细胞。
BTSCs的分化方向与NSCs明显不同。BTSCs存在明显的分化异常。